Induction of remission in a child with autoimmune enteropathy using mycophenolate mofetil

Journal of Pediatric Gastroenterology and Nutrition

Volumn 36, Issue 4, 2003, Pages 482-485

  Quirós Tejeira, Rubén E ^a,b   Ament, Marvin E ^a   Vargas, Jorge H ^a  

^a UCLA MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; CONVALESCENCE; DIARRHEA; DISEASE COURSE; DRUG DOSE REDUCTION; ENTEROPATHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; IMMUNOLOGY; INFANTILE DIARRHEA; PARENTERAL NUTRITION; REMISSION;

AUTOIMMUNE DISEASES; DIARRHEA, INFANTILE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MYCOPHENOLIC ACID; PARENTERAL NUTRITION; REMISSION INDUCTION;

EID: 0037822193     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200304000-00012     Document Type: Article

References (32)

1. Mirakian R, Richardson A, Milla PJ, et al. Protracted diarrhoea of infancy: Evidence in support of an autoimmune variant. Br Med J 1986;293:1132-36.
2. Unsworth DJ, Hutchins P, Mitchell J, et al. Flat small intestinal mucosa and autoantibodies against the gut epithelium. J Pediatr Gastroenterol Nutr 1982;1:503-13.
3. Russo PA, Brochu P, Seidman EG, Roy CC. Autoimmune enteropathy. Pediatr Dev Pathol 1999;2:65-71.
4. Savage MO, Mirakian R, Wozniak ER, et al. Specific autoantibodies to gut epithelium in two infants with severe protracted diarrhoea. J Pediatr Gastroenterol Nutr 1985;4:187-95.
5. McCarthy DM, Katz SI, Gazze L, Waldmann TA, Nelson DL, Strober W. Selective IgA deficiency associated with total villous atrophy of the small intestine and an organ-specific anti-epithelial cell antibody. J Immunol 1978;120:932-38.
6. Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy and fatal infection in infancy. J Pediatr 1982;100:731-37.
7. Ellis D, Fisher SE, Smith WI Jr., Jaffe R. Familial occurrence of renal and intestinal disease associated with tissue autoantibodies. Am J Dis Child 1982;136:323-26.
8. Walker-Smith JA, Unsworth DJ, Hutchins P, Phillips AD, Holborow EJ. Autoantibodies against gut epithelium in a child with small intestine enteropathy. Lancet 1982;1:566-67.
9. Bousvaros A, Leichtner AM, Book L, et al. Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506). Gastroenterology 1996;111:237-43.
10. Coulthard M, Searle J, Patrick M, Ravenscroft P, Cleghorn G, Shepherd R. Cyclosporine-responsive enteropathy and protracted diarrhea. J Pediatr Gastroenterol Nutr 1990;2:257-61.
11. Seidman EG, Lacaille F, Russo P, Galeano N, Murphy G, Roy CC. Successful treatment of autoimmune enteropathy with cyclosporine. J Pediatr 1990;117:929-32.
12. Colleti RB, Guillot AP, Rosen S, et al. Autoimmune enteropathy and nephropathy with circulating antiepithelial cell antibodies. J Pediatr 1991;118:858-64.
13. Moore L, Xu X, Davidson G, Moore D, Carli M, Ferrante A. Autoimmune enteropathy with anti-globet cells antibodies. Hum Pathol 1995;26:1162-68.
14. Lachaux A, Bouvier R, Cozzani E, et al. Familial autoimmune enteropathy with circulating anti-bullous pemphigoid antibodies and chronic autoimmune hepatitis. J Pediatr 1994;125:858-62.
15. Nakajima A, Ohnishi S, Mimura T, et al. Protein-losing enteropathy associated with hypocomplementemia and anti-nuclear antibodies. J Gastroenterol 2000;35:627-30.
16. Jenkins HR, Jewkes F, Vujanic GM. Systemic vasculitis complicating infantile autoimmune enteropathy. Arch Dis Child 1994;71: 534-35.
17. Kobayashi I, Imamura K, Kubota M, et al. Identification of an autoimmune enteropathy-related 75-kilodalton antigen. Gastroenterology 1999;117:823-830.
18. Murch SH, Fertleman CR, Rodrigues C, et al. Autoimmune enteropathy with distinct mucosal features in T-cell activation deficiency: The contribution of T-cells to the mucosal lesion. J Pediatr Gastroenterol Nutr 1999;28:393-99.
19. Martin-Villa JM, Regueiro JR, De Juan D, et al. T-lymphocyte dysfunction occurring together with apical gut epithelial cell autoantibodies. Gastroenterology 1991;101:390-97.
20. Martin-Villa JM, Camblor S, Costa R, Arnaiz-Villena A. Gut epithelial cell autoantibodies in AIDS pathogenesis. Lancet 1993; 342:380.
21. Mais DD, Mulhall BP, Adolphson KR, Yamamoto K. Thymoma-associated autoimmune enteropathy. A report of two cases. Am J Clin Pathol 1999;112:810-15.
22. Baud O, Goulet O, Canioni D, et al. Treatment of the Immune Dysregulation Polyendocrinopathy, Enteropathy, X-Linked Syndrome (IPEX) by Allogeneic Bone Marrow Transplant. N Engl J Med 2001;344:1758-62.
23. Pirisi-Hauck NC, Foss HD, Baier J, Kurunczi S. Simultaneous occurrence of autoimmune enteropathy and recurrent deep venous thrombosis. J Pediatr Gastroenterol Nutr 2000;30:324-29.
24. Nowak-Gottl U, Dubbers A, Kececioglu D, Koch HG, Kotthoff S, Runde J, Vielhaber H. Factor V Leiden, protein C and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr 1997;131:608-12.
25. Harris EN, Loizou S, Englert H, et al. Anticardiolipin antibodies and lupus anticoagulant. Lancet 1984;2:1099.
26. Harris EN, Ghavari AE, Boey ML, et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211-14.
27. Lipsky JJ. Mycophenolate mofetil. Lancet 1996;348:1357-59.
28. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipient. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995;60:225-32.
29. Goldblum R. Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol 1993;11(Suppl):S117-S119.
30. Epinette WW, Parker CM, Jones EL, Greist MC. Mycophenolic acid for psoriasis: A review of pharmacology, long term efficacy and safety. J Am Acad Dermatol 1987;17:962-71.
31. Neurath MF, Wanitschke R, Peters M, Krummenauer F, Meyer zum Buschenfelde KH, Schlaak JF. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease. Gut 1999;44:625-28.
32. Fickert P, Hinterleitner TA, Wenzl HH, Aichbichler BW, Petritsch W. Mycophenolate mofetil in patients with Crohn's disease. Am J Gastroenterol 1998;93:2529-32.